#Israel #Rehovot #Research Grants #Sequentify #Genomic Research

Sequentify Launches Research Grants for High-Throughput Genomic Studies

In a bold move to enhance genomic research, Sequentify has recently announced its initiative to provide research grants aimed at accelerating significant genomic studies. The company stands out with its fast, user-friendly, and scalable targeted library preparation technology, which is designed to foster widespread adoption of high-throughput genomic testing across various fields.

The Opportunity for Researchers

Sequentify invites proposals from research groups conducting genomic DNA studies utilizing human-derived samples, irrespective of the study's focus area. This initiative is particularly beneficial for those working in diverse fields such as oncology, reproductive health, infectious diseases, rare diseases, public health, and population screening.

To be eligible for these grants, researchers must meet specific criteria. Their proposed studies should involve a minimum of 5,000 human samples and require Sequentify's off-the-shelf or customized panels, which can accommodate up to 10,000 genomic targets. This broad range ensures that various levels of genomic analysis can be supported, making it easier for researchers to adopt this innovative technology.

Incentives for Selected Applicants

Those selected to receive the grants will benefit significantly. Successful applicants will obtain reagents sufficient for analyzing up to 10,000 samples, along with access to Sequentify's end-to-end analysis software. This comprehensive support aims to facilitate research processes and improve data quality, allowing for more effective conclusions and advancements in the scientific community.

Submission Guidelines

Researchers interested in applying are encouraged to summarize how this grant would positively impact their work in 250 words or less. The application period is currently open, running from April 5 to June 20, 2025. Proposals should be sent to the specified email address—applications submitted outside this timeframe will not be considered.

About Sequentify

Founded in 2021 as a spinoff from the Weizmann Institute, Sequentify is dedicated to making genomic sequencing accessible on a decentralized basis. Their commitment to addressing the challenges faced in the industry by providing quick and effective solutions has established them as a pioneering company in genomic technology. By facilitating the scaling of genomic testing through tailored protocols, Sequentify is driving the future of genomic research, particularly in clinical settings. Their core products focus on oncology, infectious disease detection, and general screening applications.

With a strong base in Rehovot, Israel, Sequentify’s mission embodies the spirit of innovation in genomic studies, making them vital players in advancing our understanding of genetics and public health concerns. Researchers looking to innovate could find this an enticing opportunity to enhance their work and contribute meaningfully to the scientific landscape.

For further inquiries regarding the grants or the application process, prospective candidates are welcome to reach out via the provided contact email. Sequentify stands ready to assist and nurture the scientific endeavors of forward-thinking researchers committed to genomic exploration.